LYMPHOPROLIFERATIVE DISORDERS

Clinical trials for LYMPHOPROLIFERATIVE DISORDERS explained in plain language.

Never miss a new study

Get alerted when new LYMPHOPROLIFERATIVE DISORDERS trials appear

Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Could a drug already approved for some cancers help patients with rare genetic tumor types?

Disease control Recruiting now

This study tests atezolizumab, a drug already approved for certain cancers, in adults and children with rare cancers that have high tumor mutational burden (TMB) or microsatellite instability (MSI). About 30 participants will receive the drug to see if it shrinks tumors or stops …

Matched conditions: LYMPHOPROLIFERATIVE DISORDERS

Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control

Last updated Apr 28, 2026 13:01 UTC

LYMPHOPROLIFERATIVE DISORDERS

Get alerted when new LYMPHOPROLIFERATIVE DISORDERS trials appear

Could a drug already approved for some cancers help patients with rare genetic tumor types?